IGF1 Deficiency, Recombinant Human Insulin-Like Growth Factor (rhIGF-1) Treatment of Short Stature Associated with IGF-1 Deficiency
Dosing Framework by Clinical Context and Biomarker Status Glutathione dosing should account for baseline oxidative stress, antioxidant capacity, and individual metabolic factors
doi:10.1016/s1383-5742(00)00050-8
Pezzola S, Antonini G, Geroni C, Beria I, Colombo M, Broggini M, Mongelli N, Leboffe L, MacArthur R, Mozzi AF, Federici G, Caccuri AM: Role of glutathione transferases in the mechanism of brostallicin activation
PRODUCT USAGE: This PRODUCT IS INTENDED AS A RESEARCH CHEMICAL ONLY
The tissue specificity of this modified ASO allows for a lower dose with no loss of efficacy